CD4 and pulmonary fibrosis: The distinctions in the percentages of CD4 + IL-6+ and CD4 + IL-17A + T cells among mice in different housing cohorts support microbiota-induced alterations to the IL-6/ STAT3/IL-17A pathway in pulmonary fibrosis.